Innovation Park Basel Area

Innovation Log

SWITZERLAND INNOVATION PARK BASEL AREA WELCOMES NEW RESIDENTS IN APRIL 2018

The Park Basel Area community is growing – we are delighted to welcome four new startups in April.

With Polyneuron Pharmaceuticals, a spin-off from University of Basel, and the Polish biotech startup Captor Therapeutics, Park Basel Area gains new experts in the field of innovative health-oriented life sciences.

The French biotech startup Algae Natural Switzerland, which aims to contribute to a healthier nutrition with its microalgae, and a recently founded medtech company in stealth mode further expand the startup portfolio.

Algae Natural Switzerland
Algae Natural Switzerland AG provides protein and/or omega-3 rich high-quality microalgae for food and feed applications. The company’s production process for organic microalgae is developed based on a sustainable and circular approach for a successful eco-conception.

Captor Therapeutics
Captor Therapeutics is a Polish biotech company developing drug candidates for the treatment of oncology and chronic inflammation.

Polyneuron Pharmaceuticals
Polyneuron Pharmaceuticals is a spin-off from the University of Basel focusing on the development of a promising new drug class to treat autoimmune disorders.

Medtech company in stealth mode.

Leave a Comment:

«You may also like»

New residents at Switzerland Innovation Park Basel Area

150 Scientists Working on Life Sciences Innovation

The community at Switzerland Innovation Park Basel Area keeps growing. We are delighted to present our…> Read more
Negotiating a grant or a subsidy for a startup

3 keys to securing a grant or subsidy for your startup

Catalyze is one of the newest residents at Switzerland Innovation Park Basel Area and a market…> Read more
Catalyze at Switzerland Innovation Park Basel Area

Non-dilutive Funding for Life Sciences Developments

Access to funding is commonly one of the main challenges for entrepreneurs. Catalyze is one of…> Read more